Plandai Biotechnology (Plandai Biotechnology) Interest Expense : $-0.03 Mil (TTM As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Plandai Biotechnology Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Plandai Biotechnology's interest expense for the six months ended in Jun. 2023 was $ -0.03 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.03 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Plandai Biotechnology's Operating Income for the six months ended in Jun. 2023 was $ -0.71 Mil. Plandai Biotechnology's Interest Expense for the six months ended in Jun. 2023 was $ -0.03 Mil. Plandai Biotechnology did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Plandai Biotechnology Interest Expense Historical Data

The historical data trend for Plandai Biotechnology's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Plandai Biotechnology Interest Expense Chart

Plandai Biotechnology Annual Data

Trend

Mar09

Mar10

Mar11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun22

Jun23

Interest Expense

Get a 7-Day Free Trial

-0.79

-0.93

-1.79

-0.12

-0.03

Plandai Biotechnology Semi-Annual Data
	Mar03	Mar04	Mar05	Mar06	Mar07	Mar08	Mar09	Mar10	Mar11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun22	Jun23
Interest Expense	Get a 7-Day Free Trial											-0.79	-0.93	-1.79	-0.12	-0.03

Plandai Biotechnology Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.03 Mil.

Plandai Biotechnology (OTCPK:PLPL) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Plandai Biotechnology's Interest Expense for the six months ended in Jun. 2023 was $-0.03 Mil. Its Operating Income for the six months ended in Jun. 2023 was $-0.71 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2023 was $0.00 Mil.

Plandai Biotechnology's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

Plandai Biotechnology did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Plandai Biotechnology (Plandai Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Plandai Biotechnology Inc (OTCPK:PLPL) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

4811 49th Street, San Diego, CA, USA, 92115

Website

http://www.plandaibiotech.com

Plandai Biotechnology Inc. manufactures highly bioavailable extracts from live plant materials.

Executives

Callum Baylis-duffield	director	FLAT 37 ISLAND HOUSE THREE MILL LANE, LONDON ENGLAND X0 E33AF
Timothy Matula	other: Former Director	175 JACKSON AVE N, SUITE 102, MINNEAPOLIS MN 55343
Brian Johnson	director	P.O. BOX 1594, FERNDALE WA 98248-1594
Roger Duffield	director, officer: President, Secretary and CFO	2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
Daron Baylis Duffield	director	2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
David Rzepnicki	director	21 HORIZON DRIVE, SARATOGA SPRINGS NY 12866